Correlation Between Denali Therapeutics and Cardiff Oncology
Can any of the company-specific risk be diversified away by investing in both Denali Therapeutics and Cardiff Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Denali Therapeutics and Cardiff Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Denali Therapeutics and Cardiff Oncology, you can compare the effects of market volatilities on Denali Therapeutics and Cardiff Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Denali Therapeutics with a short position of Cardiff Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Denali Therapeutics and Cardiff Oncology.
Diversification Opportunities for Denali Therapeutics and Cardiff Oncology
0.37 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Denali and Cardiff is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Denali Therapeutics and Cardiff Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardiff Oncology and Denali Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Denali Therapeutics are associated (or correlated) with Cardiff Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardiff Oncology has no effect on the direction of Denali Therapeutics i.e., Denali Therapeutics and Cardiff Oncology go up and down completely randomly.
Pair Corralation between Denali Therapeutics and Cardiff Oncology
Given the investment horizon of 90 days Denali Therapeutics is expected to generate 7.66 times less return on investment than Cardiff Oncology. But when comparing it to its historical volatility, Denali Therapeutics is 1.57 times less risky than Cardiff Oncology. It trades about 0.01 of its potential returns per unit of risk. Cardiff Oncology is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 231.00 in Cardiff Oncology on September 8, 2024 and sell it today you would earn a total of 0.00 from holding Cardiff Oncology or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Denali Therapeutics vs. Cardiff Oncology
Performance |
Timeline |
Denali Therapeutics |
Cardiff Oncology |
Denali Therapeutics and Cardiff Oncology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Denali Therapeutics and Cardiff Oncology
The main advantage of trading using opposite Denali Therapeutics and Cardiff Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Denali Therapeutics position performs unexpectedly, Cardiff Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardiff Oncology will offset losses from the drop in Cardiff Oncology's long position.Denali Therapeutics vs. Stoke Therapeutics | Denali Therapeutics vs. Black Diamond Therapeutics | Denali Therapeutics vs. 4D Molecular Therapeutics | Denali Therapeutics vs. Ascendis Pharma AS |
Cardiff Oncology vs. Reviva Pharmaceuticals Holdings | Cardiff Oncology vs. PDS Biotechnology Corp | Cardiff Oncology vs. Reviva Pharmaceuticals Holdings | Cardiff Oncology vs. Eyenovia |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |